Qinecsa Featured in International Pharmaceutical Industry (IPI) - Qinecsa
Qinecsa featured in International Pharmaceutical Industry (IPI) editorial
- Articles
- July 11, 2024
In her latest article for IPI, Qinecsa President, Humaira Qureshi, addresses the practical challenges of integrating medical devices into pharmacovigilance portfolios. She explores the obligations of device manufacturers and offers insights on navigating the complexities of the European Medical Device Regulation (EU MDR).
“Understanding medical device regulations is essential for pharmacovigilance professionals seeking to master device vigilance compliance and operational excellence.”
Read the full article below:
Qinecsa Solutions is dedicated to providing top-tier pharmacovigilance technology and scientific expertise, connecting life science companies with the right safety solutions.
Recent Articles
The Productivity Crisis That Persists Even Now: What Will It Take to Free Up PV Professionals to Assess Safety, Rather Than Coordinate Data?
- July 28, 2026
Embracing quantitative signal detection methods as a smaller MAH
- June 25, 2026
Real-Time Safety Signals Drive Continuous PV Insight
- May 27, 2026
From Complaint Handling to Active Surveillance
- May 5, 2026
Continuous Safety Surveillance for Medical Devices
- May 5, 2026
Are patient outcomes getting lost in safety data complexity?
- May 5, 2026